Undervalued over 20% based on DCF

Results

4963

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

4963 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MSFT
US$401.104.4%-21.6%US$2.9tUS$558.6623.813.8%0.9%Software
AMZN
US$249.891.2%11.6%US$2.7tUS$314.2329.616.4%n/aRetail
2330
NT$2,290.00-5.2%98.3%NT$59.4tNT$3,064.2931.121.3%1.0%Semiconductors
META
US$664.545.2%-5.3%US$1.7tUS$822.6923.913.7%0.3%Media
BRK.A
US$738,500.00-0.3%4.0%US$1.1tUS$758,899.0014.7-2.4%n/aDiversified Financials
LLY
US$1,169.17-3.9%53.5%US$1.0tUS$1,270.3741.216.4%0.6%Pharmaceuticals & Biotech
JPM
US$343.152.3%18.4%US$922.2bUS$366.242.61.3%1.7%Banks
XOM
US$145.956.2%30.7%US$598.9bUS$167.3823.910.6%2.8%Energy
JNJ
US$249.97-3.5%53.4%US$594.6bUS$269.9528.69.2%2.1%Pharmaceuticals & Biotech
ABBV
US$254.391.8%32.9%US$431.3bUS$266.57125.027.3%2.7%Pharmaceuticals & Biotech
PG
US$151.503.2%-2.6%US$344.7bUS$163.3521.63.5%2.9%Household
HSBA
UK£14.921.4%59.9%UK£256.2bUK£14.451.711.3%3.7%Banks
NFLX
US$74.35-1.5%-41.6%US$310.3bUS$111.0323.412.0%n/aMedia
MRK
US$127.632.0%56.6%US$305.3bUS$134.0435.321.0%2.7%Pharmaceuticals & Biotech
NESN
CHF 85.552.9%10.1%CHF 217.4bCHF 88.1924.48.3%3.6%Food, Beverage & Tobacco
BABA
US$117.495.7%0.2%US$268.5bUS$190.1317.115.9%0.9%Retail
DELL
US$391.38-13.1%215.9%US$266.7bUS$489.4330.116.1%0.6%Tech
WFC
US$88.071.3%10.5%US$265.0bUS$98.931.63.3%2.3%Banks
AZN
UK£125.94-1.9%22.3%UK£195.9bUK£157.9125.313.3%1.8%Pharmaceuticals & Biotech
300750
CN¥360.003.2%32.7%CN¥1.7tCN¥560.1520.916.7%2.2%Capital Goods
8306
JP¥3,473.000.3%76.5%JP¥39.1tJP¥3,596.362.012.2%2.8%Banks
SIE
€264.55-3.0%18.0%€208.1b€294.8926.712.5%2.0%Capital Goods
C
US$131.71-5.6%41.5%US$226.3bUS$154.401.17.8%1.8%Banks
IBM
US$219.05-25.8%-22.3%US$198.5bUS$281.0719.25.4%3.1%Software
Page 1 of 138